bioAffinity Technologies closes $3.2M public offering

Go back to bioAffinity Technologies closes $3.2M public offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

June 18, 2026 1:16 PM EDT

SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced the closing of its previously announced public offering of securities as described below for aggregate gross proceeds to the Company... More